Bios Capital Management, LP Cognition Therapeutics Inc Transaction History
Bios Capital Management, LP
- $72.6 Billion
- Q2 2025
A detailed history of Bios Capital Management, LP transactions in Cognition Therapeutics Inc stock. As of the latest transaction made, Bios Capital Management, LP holds 6,000,000 shares of CGTX stock, worth $6.6 Million. This represents 2.56% of its overall portfolio holdings.
Number of Shares
6,000,000
Previous 6,000,000
-0.0%
Holding current value
$6.6 Million
Previous $2.52 Billion
26.33%
% of portfolio
2.56%
Previous 3.19%
Shares
1 transactions
Others Institutions Holding CGTX
# of Institutions
57Shares Held
13.7MCall Options Held
0Put Options Held
0-
Pathstone Family Office, LLC Englewood, NJ2.21MShares$2.43 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.3MShares$1.43 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA702KShares$772,1340.0% of portfolio
-
Chescapmanager LLC Baltimore, MD503KShares$553,5840.02% of portfolio
-
Voss Capital, LLC Houston, TX450KShares$495,0000.01% of portfolio
About COGNITION THERAPEUTICS INC
- Ticker CGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,710,700
- Market Cap $25M
- Description
- Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, a sigma-2 receptor antagonist, which is in Phase II clinical tr...